Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh (MRCK34) Price & Analysis

― Followers

MRCK34 Stock Chart & Stats

R$81.77

-R$0.49(-0.60%)

Aug 06, 2026

―

Day’s Range― - ―

52-Week RangeR$51.86 - R$86.41

Previous CloseN/A

VolumeN/A

Average Volume (3M)2.04K

Market Cap

R$1.63T

Enterprise ValueR$1.80M

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)33208.0

Beta-0.04

Next Earnings

Oct 29, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.00

Shares Outstanding20,208,290,000

10 Day Avg. Volume2,581

30 Day Avg. Volume2,039

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh News

Merck says FDA accepts sBLA for enflonsia

Merck (MRK) announced that the U.S. FDA has accepted a supplemental Biologics License Application for enflonsia to expand...

22h ago

MRK

Merck announces Health Canada approval of KEYTRUDA for adults with MIBC

Merck (MRK) announced that KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with enfortumab vedotin, an antibody-drug conjugate, is approved...

2d ago

MRK

PFE

Merck price target raised to $116 from $113 at Morgan Stanley

Morgan Stanley analyst Terence Flynn raised the firm’s price target on Merck (MRK) to $116 from $113 and...

2d ago

MRK

Merck price target raised to $146 from $145 at Guggenheim

Guggenheim analyst Vamil Divan raised the firm’s price target on Merck (MRK) to $146 from $145 and keeps...

2d ago

MRK

Midday Fly By: Palantir, Caterpillar, McDonald’s report Q2 beats

The major averages were sharply higher once again, building on Monday’s gains as technology shares continue to lead...

3d ago

Morning Movers: Palantir and Caterpillar shares jump following quarterly results

Stock futures are modestly higher as the market looks to build on Monday’s rally, with technology shares continuing...

3d ago

Merck cuts FY26 adjusted EPS view to $2.66-$2.76 from $5.04-$5.16

FY26 consensus $2.76. Raises FY26 revenue view to $66.3B-$67.3B from $65.8B-$67B, consensus $66.89B. Outlook includes charges of $2.43...

3d ago

MRK

Merck reports Q2 adjusted EPS (13c), consensus (26c)

Reports Q2 revenue $16.6B, consensus $16.37B. “We continued to make substantial progress across our business this quarter, driven...

3d ago

MRK

Merck price target raised to $150 from $140 at Barclays

Barclays analyst Emily Field raised the firm’s price target on Merck (MRK) to $150 from $140 and keeps...

9d ago

MRK

Merck announces initial access plans for alimatravir

Merck (MRK) announced early components of a multi-faceted strategy to provide rapid, broad and sustainable access in low-...

14d ago

MRK

Merck: Solid Fundamentals and Pipeline Upside, But Full Valuation Keeps Rating at Hold as Price Target Rises to $116

Morgan Stanley analyst Terence Flynn has assigned their neutral stance on MRK stock, giving a Hold rating on...

2d ago

MRK

Merck Buy Rating Reaffirmed as Analyst Highlights Emerging HIV Franchise and Maintains $137 Price Target

Goldman Sachs analyst Asad Haider maintained a Buy rating on Merck & Company yesterday and set a price...

3d ago

MRK

MRCK34 FAQ

What was Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh’s price range in the past 12 months?

Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh lowest stock price was R$51.86 and its highest was R$86.41 in the past 12 months.

What is Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh’s market cap?

Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh’s market cap is R$1.63T.

When is Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh’s upcoming earnings report date?

Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh’s upcoming earnings report date is Oct 29, 2026 which is in 83 days.

How were Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh’s earnings last quarter?

Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh released its earnings results on Aug 04, 2026. The company reported R$0 earnings per share for the quarter, the consensus estimate of N/A by R$0.

Is Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh overvalued?

According to Wall Street analysts Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh pay dividends?

Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh does not currently pay dividends.

What is Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh’s EPS estimate?

Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh have?

Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh has 20,208,290,000 shares outstanding.

What happened to Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh’s price movement after its last earnings report?

Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh reported an EPS of R$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -3.178%.

Which hedge fund is a major shareholder of Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh?

Currently, no hedge funds are holding shares in BR:MRCK34

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology